GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:9918704
| Citation |
Boyce, S, Webb, JK, Carlson, E, Rupniak, NM, Hill, RG and Martin, JE (1999) Onset and progression of motor deficits in motor neuron degeneration (mnd) mice are unaltered by the glycine/NMDA receptor antagonist L-701,324 or the MAO-B inhibitor R(-)-deprenyl. Exp. Neurol. 155:49-58 |
|---|---|
| Abstract |
NMDA-mediated neurotoxicity and oxidative stress have been implicated in the etiology of a number of degenerative diseases including motor neuron disease. The present study examined the effect of chronic administration of the glycine/NMDA receptor antagonist L-701,324 and the monoamine oxidase B inhibitor (r)-deprenyl on the onset and rate of progression of neurological impairment in the motor neuron degeneration (mnd) mouse, a murine model of neurodegeneration. Neurological assessment of mnd mice revealed an onset of motor deficits at 6 months of age as observed by the loss of hindlimb reflex extension. By 7 months, balance was also markedly impaired as measured by deficits in rotarod performance and ability to remain on balancing beams. At 8 months of age mnd mice exhibited gross abnormalities in walking pattern; animals were unable to flex their hindlimbs and tended to walk in small labored movements. Daily administration of L-701,324 (10 mg/kg p.o.) or r(-)-deprenyl (1 mg/kg p.o.) to mnd mice from 4 to 8 months of age failed to delay the onset of symptoms or slow the rate of deterioration of motor performance. These findings suggest that excessive activation of NMDA receptors may not be involved in the pathological process leading to motor neuron dysfunction in mnd mice and do not suggest a protective effect of deprenyl on motor neurons in these mice. |
| Links |
PubMed Online version:10.1006/exnr.1998.6873 |
| Keywords |
Animals; Disease Progression; Excitatory Amino Acid Antagonists/pharmacology; Female; Male; Mice; Mice, Mutant Strains/genetics; Monoamine Oxidase Inhibitors/pharmacology; Motor Activity/drug effects; Motor Activity/physiology; Motor Neuron Disease/genetics; Motor Neuron Disease/physiopathology; Nerve Degeneration/physiopathology; Quinolones/pharmacology; Selegiline/pharmacology; Stereoisomerism |
| edit table |
Significance
Annotations
| Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
|---|---|---|---|---|---|---|---|---|
| edit table |
See also
References
See Help:References for how to manage references in GONUTS.
